Deresinski S C, Levine H B, Kelly P C, Creasman R J, Stevens D A
Am Rev Respir Dis. 1977 Dec;116(6):1116-8. doi: 10.1164/arrd.1977.116.6.1116.
This study demonstrated that the administration of a spherulin skin test to subjects whose skin-test reactions were either positive or negative, at the dose used (Usual Test Strength), did not elicit an antibody response to antigens of Coccidioides immitis or Histoplasma capsulatum, as determined by standard serologic methods. Of 32 subjects, one developed a seroconversion by the latex agglutination test. The data suggested that spherulin can be used clinically as a diagnostic reagent without affecting the serologic reactions, which are of both prognostic and diagnostic value.
本研究表明,对皮肤试验反应呈阳性或阴性的受试者,以所用剂量(常用试验强度)进行球孢子菌素皮肤试验,按照标准血清学方法测定,并未引发针对粗球孢子菌或荚膜组织胞浆菌抗原的抗体反应。在32名受试者中,有一名通过乳胶凝集试验出现了血清转化。数据表明,球孢子菌素可在临床上用作诊断试剂,而不影响具有预后和诊断价值的血清学反应。